[Federal Register Volume 82, Number 136 (Tuesday, July 18, 2017)]
[Notices]
[Pages 32829-32832]
[FR Doc No: 2017-14993]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2017-N-2428]

Agency Information Collection Activities; Proposed Collection;
Comment Request; Animal Drug Adverse Event Reporting and Recordkeeping

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA or Agency) is announcing
an opportunity for public comment on the proposed collection of certain
information by the Agency. Under the Paperwork Reduction Act of 1995
(PRA), Federal Agencies are required to publish notice in the Federal
Register concerning each proposed collection of information, including
each proposed extension of an existing collection of information, and
to allow 60 days for public comment in response to the notice. This
notice solicits comments on the information collection provisions of
FDA's existing reporting and recordkeeping requirements for animal drug
adverse events and product/manufacturing defects.

DATES: Submit either electronic or written comments on the collection
of information by September 18, 2017.

ADDRESSES: You may submit comments as follows. Please note that late,
untimely filed comments will not be considered. Electronic comments
must be submitted on or before September 18, 2017. The https://www.regulations.gov electronic filing system will accept comments until
midnight Eastern Time at the end of September 18, 2017. Comments
received by mail/hand delivery/courier (for written/paper submissions)
will be considered timely if they are postmarked or the delivery
service acceptance receipt is on or before that date.

Electronic Submissions

    Submit electronic comments in the following way:
     Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments. Comments submitted
electronically, including attachments, to https://www.regulations.gov
will be posted to

the docket unchanged. Because your comment will be made public, you are
solely responsible for ensuring that your comment does not include any
confidential information that you or a third party may not wish to be
posted, such as medical information, your or anyone else's Social
Security number, or confidential business information, such as a
manufacturing process. Please note that if you include your name,
contact information, or other information that identifies you in the
body of your comments, that information will be posted on https://www.regulations.gov.
     If you want to submit a comment with confidential
information that you do not wish to be made available to the public,
submit the comment as a written/paper submission and in the manner
detailed (see ``Written/Paper Submissions'' and ``Instructions'').

Written/Paper Submissions

    Submit written/paper submissions as follows:
     Mail/Hand delivery/Courier (for written/paper
submissions): Dockets Management Staff (HFA-305), Food and Drug
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
     For written/paper comments submitted to the Dockets
Management Staff, FDA will post your comment, as well as any
attachments, except for information submitted, marked and identified,
as confidential, if submitted as detailed in ``Instructions.''
    Instructions: All submissions received must include the Docket No.
FDA-2017-N-2428 for ``Animal Drug Adverse Event Reporting and
Recordkeeping.'' Received comments, those filed in a timely manner (see
DATES), will be placed in the docket and, except for those submitted as
``Confidential Submissions,'' publicly viewable at https://www.regulations.gov or at the Dockets Management Staff between 9 a.m.
and 4 p.m., Monday through Friday.
     Confidential Submissions--To submit a comment with
confidential information that you do not wish to be made publicly
available, submit your comments only as a written/paper submission. You
should submit two copies total. One copy will include the information
you claim to be confidential with a heading or cover note that states
``THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.'' The Agency will
review this copy, including the claimed confidential information, in
its consideration of comments. The second copy, which will have the
claimed confidential information redacted/blacked out, will be
available for public viewing and posted on https://www.regulations.gov.
Submit both copies to the Dockets Management Staff. If you do not wish
your name and contact information to be made publicly available, you
can provide this information on the cover sheet and not in the body of
your comments and you must identify this information as
``confidential.'' Any information marked as ``confidential'' will not
be disclosed except in accordance with 21 CFR 10.20 and other
applicable disclosure law. For more information about FDA's posting of
comments to public dockets, see 80 FR 56469, September 18, 2015, or
access the information at: https://www.gpo.gov/fdsys/pkg/FR-2015-09-18/pdf/2015-23389.pdf.
    Docket: For access to the docket to read background documents or
the electronic and written/paper comments received, go to https://www.regulations.gov and insert the docket number, found in brackets in
the heading of this document, into the ``Search'' box and follow the
prompts and/or go to the Dockets Management Staff, 5630 Fishers Lane,
Rm. 1061, Rockville, MD 20852.

FOR FURTHER INFORMATION CONTACT: Ila S. Mizrachi, Office of Operations,
Food and Drug Administration, Three White Flint North, 10A63, 11601
Landsdown St., North Bethesda, MD 20852,<PHONE_NUMBER>,
<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION: Under the PRA (44 U.S.C. 3501-3520), Federal
Agencies must obtain approval from the Office of Management and Budget
(OMB) for each collection of information they conduct or sponsor.
``Collection of information'' is defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes Agency requests or requirements that members of
the public submit reports, keep records, or provide information to a
third party. Section 3506(c)(2)(A) of the PRA (44 U.S.C. 3506(c)(2)(A))
requires Federal Agencies to provide a 60-day notice in the Federal
Register concerning each proposed collection of information, including
each proposed extension of an existing collection of information,
before submitting the collection to OMB for approval. To comply with
this requirement, FDA is publishing notice of the proposed collection
of information set forth in this document.
    With respect to the following collection of information, FDA
invites comments on these topics: (1) Whether the proposed collection
of information is necessary for the proper performance of FDA's
functions, including whether the information will have practical
utility; (2) the accuracy of FDA's estimate of the burden of the
proposed collection of information, including the validity of the
methodology and assumptions used; (3) ways to enhance the quality,
utility, and clarity of the information to be collected; and (4) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques, when
appropriate, and other forms of information technology.

Animal Drug Adverse Event Reporting and Recordkeeping--21 U.S.C.
360b(l), 21 CFR 510.301 and 514.80 OMB Control Number 0910-0284--
Extension

    With regard to adverse events and product/manufacturing defects
associated with approved new animal drugs, section 512(l) of the
Federal Food, Drug, and Cosmetic Act (the FD&C Act) (21 U.S.C. 360b(l))
requires applicants with approved new animal drug applications (NADAs)
and abbreviated new animal drug applications (ANADAs) to establish and
maintain records and reports of data relating to experience with uses
of such drug, or with respect to animal feeds bearing or containing
such drug, to facilitate a determination under section 512(e) as to
whether there may be grounds for suspending or withdrawing approval of
the NADA or ANADA under section 512(e) or 512(m)(4). Sections 571(e)(3)
and 512(e)(2) of the FD&C Act (21 U.S.C. 360ccc(e)(3) and 360b(e)(2))
require that applicants with conditionally approved new animal drug
applications (CNADAs) maintain adequate records and make reports in
accordance with a regulation or order issued under section 512(l).
Finally, section 512(m)(5) of the FD&C Act requires an applicant for a
license to manufacture animal feeds bearing or containing new animal
drugs to maintain adequate records and make reports ``as the Secretary
may by general regulation, or by order with respect to such
application, prescribe on the basis of a finding that such records and
reports are necessary in order to enable the Secretary to determine''
whether there may be grounds for suspending or withdrawing approval of
the new animal drug under section 512(e) or a license to manufacture
animal feeds bearing or containing new animal drugs under section
512(m)(4).
    Section 514.80 of our regulations (21 CFR 514.80) sets forth the
recordkeeping and reporting requirements for applicants and
nonapplicants of approved NADAs and ANADAs. Section 510.301 of our
regulations (21 CFR 510.301) sets forth the recordkeeping and reporting
requirements for licensed medicated feed manufacturing facilities.

Recordkeeping and Reporting Requirements for Applicants of Approved
NADAs and ANADAs

    Section 514.80 requires applicants to keep records of and report to
us data, studies, and other information concerning experience with new
animal drugs for each approved NADA and ANADA. Following complaints
from animal owners or veterinarians or following their own detection of
a problem, applicants are required to submit adverse event reports and
product defect reports under Sec.  514.80(b)(1), (b)(2)(i) and (ii),
(b)(3), and (b)(4)(iv)(A) on Form FDA 1932. Form FDA 1932a (the
voluntary reporting form) is used by veterinarians and the general
public to submit adverse event reports, product defects, and lack of
effectiveness complaints directly to FDA. Form FDA 2301 is used by
applicants to submit the required transmittal of periodic reports
(Sec.  514.80(b)(4)); special drug experience reports (Sec.
514.80(b)(5)(i)); promotional material for new animal drugs (Sec.
514.80(b)(5)(ii)); and distributor statements (Sec.
514.80(b)(5)(iii)). We review the records and reports required in Sec.
514.80 and the voluntary reports to facilitate a determination under
section 512(e) of the FD&C Act as to whether there may be grounds for
suspending or withdrawing approval of the new animal drug. We have made
minor editorial revisions to Form FDA 1932a, to clarify how to report
adverse drug events associated with compounded products using that
form. Submitters are already reporting adverse drug events associated
with compounded products on Form FDA 1932a. The clarifications include:
The addition of a new question, ``Is this a compounded product''; the
addition of a new field to allow the submitter to provide product
strength, ``Strength of Active Ingredient(s)''; modifying the title of
the existing field requesting the name of manufacturer, so that it
reads, ``Name of Manufacturer or Compounding Pharmacy/Compounder of
Suspected Product''; and a request for contact information for the
manufacturer or compounder. We estimate that the revisions will not
change the average amount of time necessary to complete the form.

Recordkeeping and Reporting Requirements for Applicants of CNADAs

    As noted, sections 571(e)(3) and 512(e)(2) of the FD&C Act require
that applicants for CNADAs maintain adequate records and make reports
in accordance with a regulation or order issued under section 512(l) of
the FD&C Act. Moreover, section 512(l) requires submission of such
information as required ``by general regulation, or by order . . .''
Conditional approval letters explicitly establish an order requiring
the submission of postmarketing information in accordance with the
requirements of Sec.  514.80. Applicants submit adverse event reports
and product defect reports on Form FDA 1932.

Recordkeeping and Reporting Requirements for Licensed Medicated Feed
Manufacturing Facilities

    Section 510.301 requires a licensed medicated feed manufacturer to
keep records of and report to us information concerning experience with
animal feeds bearing or containing approved new animal drugs. Under
Sec.  510.301(a), a licensed medicated feed manufacturer must
immediately report to us information concerning any mixup in the new
animal drug or its labeling; any bacterial or significant chemical,
physical, or other change or deterioration in a drug; and any failure
of one or more distributed batches of a drug to meet the specifications
established for it. Under Sec.  510.301(b), a licensed medicated feed
manufacturer must report to us within 15 working days of receipt of
information concerning any unexpected side effect, injury, toxicity, or
sensitivity reaction or any unexpected incidence or severity thereof,
and any unusual failure of the new animal drug to exhibit its expected
pharmacological activity. OMB initially approved the information
collection provisions of Sec.  510.301 under control number 0910-0012.
That approval was subsequently consolidated into this collection in
2004. We reviewed the records and reports required by Sec.  510.301 to
facilitate a determination as to whether there may be grounds for
suspending or withdrawing approval of the new animal drug under section
512(e) of the FD&C Act, or grounds for revoking a license to
manufacture medicated feed under section 512(m)(4).
    Since the consolidation of the 0910-0012 collection into this
collection in 2004, we have included the estimated number of medicated
feed adverse event reports as part of our estimate of the number of all
mandatory adverse event reports for new animal drugs. To improve the
clarity of our estimates we have added a row to table 1, on which we
separately report our estimates of medicated feed reports.
    The continuous monitoring of approved NADAs, ANADAs, CNADAs, and
animal feeds bearing or containing new animal drugs affords the primary
means by which we obtain information regarding potential problems with
the safety and efficacy of marketed approved new animal drugs, as well
as potential product/manufacturing problems. Postapproval marketing
surveillance is important because data previously submitted to us may
not be adequate as animal drug effects can change over time and less
apparent effects may take years to manifest.
    Description of respondents: Respondents to this collection of
information are animal drug manufacturers with approved NADAs, ANADAs,
or CNADAs, as well as licensed commercial feed mills and licensed
mixer-feeders.
    FDA estimates the burden of this collection of information as
follows:

                                                     Table 1--Estimated Annual Reporting Burden \1\
--------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                           Number of
               Activity                    FDA Form        Number of     responses per   Total annual      Average burden per response      Total hours
                                                          respondents     respondent       responses
--------------------------------------------------------------------------------------------------------------------------------------------------------
Medicated feed reports, Sec.                       N/A               5               1               5  .25 (15 minutes)................            1.25
 510.301(a) and (b).
Mandatory adverse event reporting, 21             1932              22              81           1,782  1...............................           1,782
 U.S.C. 360b(l); Sec.   514.80(b)(1);
 (b)(2)(i) and (ii); (b)(3); and
 (b)(4)(iv)(A).
Voluntary adverse event reporting by             1932a             197               1             197  1...............................             197
 veterinarians and the general public.
Periodic drug experience reports, Sec.            2301             200            8.11           1,622  16..............................          25,952
   514.80(b)(4).

Special drug experience reports, Sec.             2301             200            0.57             114  2...............................             228
  514.80(b)(5)(i).
Submission of advertisements and                  2301             200           20.12           4,024  2...............................           8,048
 promotional labeling, Sec.
 514.80(b)(5)(ii).
Submission of distributor statements,             2301             190             0.1              19  2...............................              38
 Sec.   514.80(b)(5)(iii).
                                       -----------------------------------------------------------------------------------------------------------------
    Total.............................  ..............  ..............  ..............  ..............  ................................       36,246.25
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of information.

    We base our reporting estimates on our experience with adverse
event reporting for approved new animal drugs and the number of reports
received in the previous 3 years.

                               Table 2--Estimated Annual Recordkeeping Burden \1\
----------------------------------------------------------------------------------------------------------------
                                                     Number of                    Average burden
            Activity                 Number of      records per    Total annual         per         Total hours
                                   recordkeepers   recordkeeper       records      recordkeeping
----------------------------------------------------------------------------------------------------------------
Recordkeeping, Sec.   510.301                  5               1               5               4              20
 \2\............................
Recordkeeping, 21 U.S.C. 360b(l)          646.70            7.19         4,649.8              14          65,097
 and Sec.   514.80(e) \3\.......
                                 -------------------------------------------------------------------------------
    Total.......................  ..............  ..............  ..............  ..............          65,117
----------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of
  information.
\2\ This estimate includes all recordkeeping by licensed medicated feed manufacturers under Sec.   510.301.
\3\ This estimate includes all recordkeeping by applicants of approved NADAs, ANADAs, and CNADAs under Sec.
  514.80(e).

    We base our recordkeeping estimates on our experience with adverse
event reporting for approved new animal drugs and the number of reports
received in the previous 3 years. Since the consolidation of the 0910-
0012 collection into this collection in 2004, we have included the
estimated recordkeeping burden for medicated feed adverse event reports
as part of our estimate of the recordkeeping burden of all mandatory
adverse event reports for new animal drugs. To improve the clarity of
our estimates we have added a row to table 2, on which we separately
report our recordkeeping estimate for medicated feed adverse event
reports (20 hours).
    The burden of this collection has changed. Due to the addition of a
new row to table 1 and a new row to table 2, there was a slight
increase in the estimated number of reports submitted to FDA under
total annual responses (by 7.8 responses). The overall decrease in
burden hours (by 1.75 hours) is due to the normal variation in the
submission of reports to FDA.
    We continually strive to improve our systems for collecting and
analyzing drug experience reports and adverse event reports. To that
end, we have developed an electronic submission system by which Form
FDA 2301 may be submitted to the Agency. For Form FDA 1932a, we have a
fillable electronic form available online, which can be submitted by
email to FDA Center for Veterinary Medicine. We specifically invite
comment from respondents on the utility of these reporting forms.
Electronic adverse event reporting for approved new animal drugs
(including mandatory reporting under Sec.  514.80(b) and voluntary
reporting) has been approved under OMB control number 0910-0645.
Reporting and recordkeeping associated with the index of legally
marketed unapproved new animal drugs for minor species (21 CFR part
516) is approved under OMB control number 0910-0620.

    Dated: July 11, 2017.
Anna K. Abram,
Deputy Commissioner for Policy, Planning, Legislation, and Analysis.
[FR Doc. 2017-14993 Filed 7-17-17; 8:45 am]
 BILLING CODE 4164-01-P


[Federal Register Volume 83, Number 223 (Monday, November 19, 2018)]
[Notices]
[Pages 58245-58246]
[FR Doc No: 2018-25178]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Project No. 12611-009]

Verdant Power, LLC; Notice of Intent To File License Application,
Filing of Pre-Application Document, and Approving Use of the
Traditional Licensing Process

    a. Type of Application: Notice of Intent to File License
Application and

Request to Use the Traditional Licensing Process.
    b. Project No.: 12611-009.
    c. Date filed: August 31, 2018.
    d. Submitted by: Verdant Power, LLC.
    e. Name of Project: Roosevelt Island Tidal Energy Project.
    f. Location: On the East River in New York City, New York. No
federal lands are occupied by the project works or located within the
project boundary.
    g. Filed Pursuant to: 18 CFR 5.3 of the Commission's regulations.
    h. Potential Applicant Contact: Mr. Ronald F. Smith, President,
Verdant Power, LLC, 20 River Road, Suite 20C, Roosevelt Island, New
York, NY 10044, Phone:<PHONE_NUMBER>, Email: [email protected].
    i. FERC Contact: Andy Bernick, Phone:<PHONE_NUMBER>, Email:
[email protected].
    j. Verdant Power, LLC filed a request to use the Traditional
Licensing Process on August 31, 2018 and provided public notice of its
request on September 28, 2018. In a letter dated November 13, 2018, the
Director of the Division of Hydropower Licensing approved Verdant
Power, LLC's request to use the Traditional Licensing Process.
    k. With this notice, we are initiating informal consultation with
the U.S. Fish and Wildlife Service and/or NOAA Fisheries under section
7 of the Endangered Species Act and the joint agency regulations
thereunder at 50 CFR, Part 402; and NOAA Fisheries under section 305(b)
of the Magnuson-Stevens Fishery Conservation and Management Act and
implementing regulations at 50 CFR 600.920. We are also initiating
consultation with the New York State Historic Preservation Office, as
required by section 106, National Historic Preservation Act, and the
implementing regulations of the Advisory Council on Historic
Preservation at 36 CFR 800.2.
    l. With this notice, we are designating Verdant Power, LLC as the
Commission's non-federal representative for carrying out informal
consultation pursuant to section 7 of the Endangered Species Act and
consultation pursuant to section 106 of the National Historic
Preservation Act.
    m. Verdant Power, LLC filed a Pre-Application Document (PAD;
including a proposed process plan and schedule) with the Commission,
pursuant to 18 CFR 5.6 of the Commission's regulations.
    n. A copy of the PAD is available for review at the Commission in
the Public Reference Room or may be viewed on the Commission's website
(http://www.ferc.gov), using the ``eLibrary'' link. Enter the docket
number, excluding the last three digits in the docket number field to
access the document. For assistance, contact FERC Online Support at
[email protected],<PHONE_NUMBER> (toll free), or (202) 502-
8659 (TTY). A copy is also available for inspection and reproduction at
the address in paragraph h.
    o. The licensee states its unequivocal intent to submit an
application for a subsequent license for Project No. 12611. Pursuant to
18 CFR 16.8, 16.9, and 16.10 each application for a subsequent license
and any competing license applications must be filed with the
Commission at least 24 months prior to the expiration of the existing
license. All applications for license for this project must be filed by
December 31, 2019.
    p. Register online at http://www.ferc.gov/docs-filing/esubscription.asp to be notified via email of new filing and issuances
related to this or other pending projects. For assistance, contact FERC
Online Support.

    Dated: November 13, 2018.
Kimberly D. Bose,
Secretary.
[FR Doc. 2018-25178 Filed 11-16-18; 8:45 am]
 BILLING CODE 6717-01-P


[Federal Register Volume 82, Number 174 (Monday, September 11, 2017)]
[Notices]
[Page 42666]
[FR Doc No: 2017-19158]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. ER17-2376-000]

GenOn Holdco 9, LLC; Supplemental Notice That Initial Market-
Based Rate Filing Includes Request for Blanket Section 204
Authorization

    This is a supplemental notice in the above-referenced proceeding,
of GenOn Holdco 9, LLC's application for market-based rate authority,
with an accompanying rate tariff, noting that such application includes
a request for blanket authorization, under 18 CFR part 34, of future
issuances of securities and assumptions of liability.
    Any person desiring to intervene or to protest should file with the
Federal Energy Regulatory Commission, 888 First Street NE., Washington,
DC 20426, in accordance with Rules 211 and 214 of the Commission's
Rules of Practice and Procedure (18 CFR 385.211 and 385.214). Anyone
filing a motion to intervene or protest must serve a copy of that
document on the Applicant.
    Notice is hereby given that the deadline for filing protests with
regard to the applicant's request for blanket authorization, under 18
CFR part 34, of future issuances of securities and assumptions of
liability, is September 25, 2017.
    The Commission encourages electronic submission of protests and
interventions in lieu of paper, using the FERC Online links at http://www.ferc.gov. To facilitate electronic service, persons with Internet
access who will eFile a document and/or be listed as a contact for an
intervenor must create and validate an eRegistration account using the
eRegistration link. Select the eFiling link to log on and submit the
intervention or protests.
    Persons unable to file electronically should submit an original and
5 copies of the intervention or protest to the Federal Energy
Regulatory Commission, 888 First Street NE., Washington, DC 20426.
    The filings in the above-referenced proceeding are accessible in
the Commission's eLibrary system by clicking on the appropriate link in
the above list. They are also available for electronic review in the
Commission's Public Reference Room in Washington, DC. There is an
eSubscription link on the Web site that enables subscribers to receive
email notification when a document is added to a subscribed docket(s).
For assistance with any FERC Online service, please email
<EMAIL_ADDRESS>or call<PHONE_NUMBER> (toll free). For TTY,
call<PHONE_NUMBER>.

    Dated: September 5, 2017.
Nathaniel J. Davis, Sr.,
Deputy Secretary.
[FR Doc. 2017-19158 Filed 9-8-17; 8:45 am]
 BILLING CODE 6717-01-P


[Federal Register: July 1, 2008 (Volume 73, Number 127)]
[Notices]
[Page 37465-37466]
[DOCID:fr01jy08-48]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2008-N-0146]

Agency Information Collection Activities; Submission for Office
of Management and Budget Review; Comment Request; Requirements for
Collection of Data Relating to the Prevention of Medical Gas Mix-ups at
Health Care Facilities-Survey

AGENCY:  Food and Drug Administration, HHS.

ACTION:  Notice.

-----------------------------------------------------------------------

SUMMARY:  The Food and Drug Administration (FDA) is announcing

that a proposed collection of information has been submitted to the
Office of Management and Budget (OMB) for review and clearance under
the Paperwork Reduction Act of 1995.

DATES: Fax written comments on the collection of information by July
31, 2008

ADDRESSES:  To ensure that comments on the information collection are
received, OMB recommends that written comments be faxed to the Office
of Information and Regulatory Affairs, OMB, Attn: FDA Desk Officer,
FAX:<PHONE_NUMBER>, or e-mailed to<EMAIL_ADDRESS>All comments
should be identified with the OMB control number 0910-0548. Also
include the FDA docket number found in brackets in the heading of this
document.

FOR FURTHER INFORMATION CONTACT:  Elizabeth Berbakos, Office of the
Chief Information Officer (HFA-250), Food and Drug Administration, 5600
Fishers Lane, Rockville, MD 20857,<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION: In compliance with 44 U.S.C. 3507, FDA has
submitted the following proposed collection of information to OMB for
review and clearance.

Requirements for Collection of Data Relating to the Prevention of
Medical Gas Mix-ups at Health Care Facilities-Survey--(OMB Control
Number 0910-0548)--Extension

    FDA has received four reports of medical gas mix-ups occurring
during the past 9 years. These reports were received from hospitals and
nursing homes and involved 7 deaths and 15 injuries to patients who
were thought to be receiving medical grade oxygen, but who were
actually receiving a different gas (e.g., nitrogen, argon) that had
been mistakenly connected to the facility's oxygen supply system. In
2001, FDA published guidance making recommendations to help hospitals,
nursing homes, and other health care facilities avoid the tragedies
that result from medical gas mix-ups and alerting these facilities to
the hazards. This survey is intended to assess the degree of
facilities' compliance with safety measures to prevent mix-ups, to
determine if further steps are warranted to ensure the safety of
patients.
    In the Federal Register of March 7, 2008 (73 FR 12452), FDA
published a 60-day notice requesting public comment on the information
collection provisions. No comments were received.

                                 Table 1.--Estimated Annual Reporting Burden\1\
----------------------------------------------------------------------------------------------------------------
                         No. of        Annual Frequency     Total Annual        Hours per
  21 CFR Section      Respondents        per Response        Responses           Response         Total Hours
----------------------------------------------------------------------------------------------------------------
210 and 211                      285                  1                285                .25              71.25
----------------------------------------------------------------------------------------------------------------
Total                            285                  1                285                .25              71.25
----------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of
  information.

    Dated: June 24, 2008.
Jeffrey Shuren,
Associate Commissioner for Policy and Planning.
[FR Doc. E8-14888 Filed 6-30-08; 8:45 am]

BILLING CODE 4160-01-S


[Federal Register Volume 76, Number 219 (Monday, November 14, 2011)]
[Notices]
[Pages 70516-70517]
[FR Doc No: 2011-29252]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

Proposed Collection; Comment Request

Upon Written Request, Copies Available From: Securities and Exchange
Commission, Office of Investor Education and Advocacy, Washington, DC
20549-0213.

    Extension:
Rules 17Ad-6 and 17Ad-7, SEC File No. 270-151, OMB Control No. 3235-
0291.

    Notice is hereby given that, pursuant to the Paperwork Reduction
Act of 1995 (44 U.S.C. 3501 et seq.), the Securities and Exchange
Commission (``Commission'') is soliciting comments on the existing
collection of information provided for in Rule 17Ad-6 (17 CFR 240.17Ad-
6) and Rule 17Ad-7 (17 CFR

240.17Ad-7) under the Securities Exchange Act of 1934 (15 U.S.C. 78a et
seq.) (``Exchange Act''). The Commission plans to submit this existing
collection of information to the Office of Management and Budget for
extension and approval.
    Rule 17Ad-6 requires every registered transfer agent to make and
keep current records about a variety of information, such as: (1)
Specific operational data regarding the time taken to perform transfer
agent activities (to ensure compliance with the minimum performance
standards in Rule 17Ad-2 (17 CFR 240.17Ad-2); (2) written inquiries and
requests by shareholders and broker-dealers and response time thereto;
(3) resolutions, contracts or other supporting documents concerning the
appointment or termination of the transfer agent; (4) stop orders or
notices of adverse claims to the securities; and (5) all canceled
registered securities certificates.
    Rule 17Ad-7 requires each registered transfer agent to retain the
records specified in Rule 17Ad-6 in an easily accessible place for a
period of six months to six years, depending on the type of record or
document. Rule 17Ad-7 also specifies the manner in which records may be
maintained using electronic, microfilm, and microfiche storage methods.
    These recordkeeping requirements are designed to ensure that all
registered transfer agents are maintaining the records necessary for
them to monitor and keep control over their own performance and for the
Commission to adequately examine registered transfer agents on an
historical basis for compliance with applicable rules.
    The Commission estimates that approximately 473 registered transfer
agents will spend a total of 236,500 hours per year complying with
Rules 17Ad-6 and 17Ad-7 (500 hours per year per transfer agent).
    Written comments are invited on: (a) Whether the proposed
collection of information is necessary for the proper performance of
the functions of the Commission, including whether the information
shall have practical utility; (b) the accuracy of the Commission's
estimates of the burden of the proposed collection of information; (c)
ways to enhance the quality, utility, and clarity of the information on
respondents; and (d) ways to minimize the burden of the collection of
information on respondents, including through the use of automated
collection techniques or other forms of information technology.
Consideration will be given to comments and suggestions submitted in
writing within 60 days of this publication.
    The Commission may not conduct or sponsor a collection of
information unless it displays a currently valid control number. No
person shall be subject to any penalty for failing to comply with a
collection of information subject to the PRA that does not display a
valid Office of Management and Budget control number.
    Please direct your written comments to: Thomas Bayer, Director/
Chief Information Officer, Securities and Exchange Commission, c/o Remi
Pavlik-Simon, 6432 General Green Way, Alexandria, Virginia 22312 or
send an email to<EMAIL_ADDRESS>
    Dated: November 7, 2011.
Kevin M. O'Neill,
Deputy Secretary.
[FR Doc. 2011-29252 Filed 11-10-11; 8:45 am]
BILLING CODE 8011-01-P


[Federal Register: August 13, 2007 (Volume 72, Number 155)]
[Rules and Regulations]
[Page 45151-45153]
[DOCID:fr13au07-3]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Aviation Administration

14 CFR Part 39

[Docket No. FAA-2007-28940; Directorate Identifier 2007-NM-131-AD;
Amendment 39-15158; AD 2007-16-19]
RIN 2120-AA64

Airworthiness Directives; Boeing Model 747-200B, 747-300, and
747-400 Series Airplanes

AGENCY: Federal Aviation Administration (FAA), Department of
Transportation (DOT).

ACTION: Final rule; request for comments.

-----------------------------------------------------------------------

SUMMARY: The FAA is adopting a new airworthiness directive (AD) for
certain Boeing Model 747-200B, 747-300, and 747-400 series airplanes.
This AD requires doing repetitive detailed inspections for cracking of
the aft tension tie channels from body station (BS) 1120 to BS 1220 and
from BS 880 to BS 1100, and corrective actions if necessary. This AD
results from cracks found in the aft tension tie channels at four
station locations, on a Model 747-200B series airplane that had been
modified to a special freighter. We are issuing this AD to detect and
correct cracking of the aft tension tie channels; failure of more than
one tension tie could result in rapid depressurization of the airplane.

DATES: This AD becomes effective August 28, 2007.
    The Director of the Federal Register approved the incorporation by
reference of certain publications listed in the AD as of August 28,
2007.
    We must receive comments on this AD by October 12, 2007.

ADDRESSES: Use one of the following addresses to submit comments on
this AD.
     DOT Docket Web site: Go to http://dms.dot.gov and follow

the instructions for sending your comments electronically.
     Government-wide rulemaking Web site: Go to http://www.regulations.gov
 and follow the instructions for sending your

comments electronically.
     Mail: U.S. Department of Transportation, Docket
Operations, M-30, West Building Ground Floor, Room W12-140, 1200 New
Jersey Avenue, SE., Washington, DC 20590.
     Fax:<PHONE_NUMBER>.
     Hand Delivery: Room W12-140 on the ground floor of the
West Building, 1200 New Jersey Avenue, SE., Washington, DC, between 9
a.m. and 5 p.m., Monday through Friday, except Federal holidays.
    Contact Boeing Commercial Airplanes, P.O. Box 3707, Seattle,
Washington 98124-2207, for service information identified in this AD.

FOR FURTHER INFORMATION CONTACT: Ivan Li, Aerospace Engineer, Airframe
Branch, ANM-120S, FAA, Seattle Aircraft Certification Office, 1601 Lind
Avenue, SW., Renton, Washington 98057-3356; telephone<PHONE_NUMBER>;
fax<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION:

Discussion

    We have received a report indicating that cracks were found in the
aft tension tie channels at four station locations, on a Model 747-200B
series airplane that

had been modified to a special freighter. The cracks were found near
the body frames at a location where the flanges of the aft tension tie
channels are machined down to a flat plate in order to attach to the
body frames. The largest crack was approximately 0.5 inch in length.
The airplane had accumulated 4,856 flight cycles since modification to
special freighter. Tension ties are considered to be structurally
significant, in that they are critical to airplane structural
integrity. Failure of more than one tension tie, if not corrected,
could result in rapid depressurization of the airplane.
    The upper deck tension ties on Model 747-300 and -400 series
airplanes that have been modified to a special freighter configuration
are similar to those on the affected Model 747-200B series airplanes
that have been modified to a special freighter configuration.
Therefore, all of these airplanes are subject to the same unsafe
condition.

Relevant Service Information

    We have reviewed Boeing Alert Service Bulletin 747-53A2610, dated
May 10, 2007. The service bulletin describes procedures for doing
repetitive detailed inspections for cracking of the aft tension tie
channels from body station (BS) 1120 to BS 1220 and from BS 880 to BS
1100, and doing corrective actions as applicable. The corrective
actions include repairing any crack found in a tension tie, and
contacting Boeing for repair instructions if any crack is found in a
bolt hole. The service bulletin specifies that, as an option to
accomplishing the repetitive detailed inspections, accomplishing the
repairs at all tension tie locations can be done as a preventive
modification.
    The service bulletin specifies accomplishing the initial inspection
from BS 1120 to BS 1220 before the accumulation of 4,000 flight cycles
since modification to special freighter or converted freighter, or
within 1,000 flight cycles after the date on the service bulletin,
whichever occurs later. The service bulletin specifies accomplishing
the initial inspection from BS 880 to BS 1100 before the accumulation
of 8,000 flight cycles since modification to special freighter or
converted freighter, or within 1,000 flight cycles after the date on
the service bulletin, whichever occurs later. The service bulletin also
specifies repeating the inspections at intervals not to exceed 4,000
flight cycles. The service bulletin also specifies repairing any crack
before further flight.
    Accomplishing the actions specified in the service information is
intended to adequately address the unsafe condition.

FAA's Determination and Requirements of This AD

    The unsafe condition described previously is likely to exist or
develop on other airplanes of the same type design that may be
registered in the U.S. at some time in the future. Therefore, we are
issuing this AD to detect and correct cracking of the aft tension tie
channels; failure of more than one tension tie could result in rapid
depressurization of the airplane. This AD requires accomplishing the
actions specified in the service information described previously,
except as discussed under ``Difference Between the AD and Service
Bulletin.''

Difference Between the AD and Service Bulletin

    The service bulletin specifies to contact the manufacturer for
instructions on how to repair certain conditions, but this proposed AD
would require repairing those conditions in one of the following ways:
     Using a method that we approve; or
     Using data that meet the certification basis of the
airplane, and that have been approved by an Authorized Representative
for the Boeing Commercial Airplanes Delegation Option Authorization
Organization whom we have authorized to make those findings.

Costs of Compliance

    If an affected airplane is imported and placed on the U.S. Register
in the future, the required inspections would take about 4 work hours
per airplane, at an average labor rate of $80 per work hour. Based on
these figures, the estimated cost of the AD would be $320 per airplane,
per inspection cycle.

FAA's Determination of the Effective Date

    No airplane affected by this AD is currently on the U.S. Register.
Therefore, providing notice and opportunity for public comment is
unnecessary before this AD is issued, and this AD may be made effective
in less than 30 days after it is published in the Federal Register.

Comments Invited

    This AD is a final rule that involves requirements that affect
flight safety and was not preceded by notice and an opportunity for
public comment; however, we invite you to submit any relevant written
data, views, or arguments regarding this AD. Send your comments to an
address listed under the ADDRESSES section. Include ``Docket No. FAA-
2007-28940; Directorate Identifier 2007-NM-131-AD'' at the beginning of
your comments. We specifically invite comments on the overall
regulatory, economic, environmental, and energy aspects of the AD that
might suggest a need to modify it.
    We will post all comments we receive, without change, to http://dms.dot.gov
, including any personal information you provide. We will

also post a report summarizing each substantive verbal contact with FAA
personnel concerning this AD. Using the search function of that web
site, anyone can find and read the comments in any of our dockets,
including the name of the individual who sent the comment (or signed
the comment on behalf of an association, business, labor union, etc.).
You may review the DOT's complete Privacy Act Statement in the Federal
Register published on April 11, 2000 (65 FR 19477-78), or you may visit
http://dms.dot.gov.

Examining the Docket

    You may examine the AD docket on the Internet at http://dms.dot.gov
, or in person at the Docket Operations office between 9

a.m. and 5 p.m., Monday through Friday, except Federal holidays. The
Docket Operations office (telephone<PHONE_NUMBER>) is located on the
ground level of the West Building at the DOT street address stated in
the ADDRESSES section. Comments will be available in the AD docket
shortly after the Docket Management System receives them.

Authority for This Rulemaking

    Title 49 of the United States Code specifies the FAA's authority to
issue rules on aviation safety. Subtitle I, Section 106, describes the
authority of the FAA Administrator. Subtitle VII, Aviation Programs,
describes in more detail the scope of the Agency's authority.
    We are issuing this rulemaking under the authority described in
Subtitle VII, Part A, Subpart III, Section 44701, ``General
requirements.'' Under that section, Congress charges the FAA with
promoting safe flight of civil aircraft in air commerce by prescribing
regulations for practices, methods, and procedures the Administrator
finds necessary for safety in air commerce. This regulation is within
the scope of that authority because it addresses an unsafe condition
that is likely to exist or develop on products identified in this
rulemaking action.

Regulatory Findings

    We have determined that this AD will not have federalism
implications under Executive Order 13132. This AD will not have a
substantial direct effect on the States, on the relationship between
the national government and the States, or on the distribution of power
and responsibilities among the various levels of government.
    For the reasons discussed above, I certify that the regulation:
    1. Is not a ``significant regulatory action'' under Executive Order
12866;
    2. Is not a ``significant rule'' under the DOT Regulatory Policies
and Procedures (44 FR 11034, February 26, 1979); and
    3. Will not have a significant economic impact, positive or
negative, on a substantial number of small entities under the criteria
of the Regulatory Flexibility Act.
    We prepared a regulatory evaluation of the estimated costs to
comply with this AD and placed it in the AD docket. See the ADDRESSES
section for a location to examine the regulatory evaluation.

List of Subjects in 14 CFR Part 39

    Air transportation, Aircraft, Aviation safety, Incorporation by
reference, Safety.

Adoption of the Amendment

0
Accordingly, under the authority delegated to me by the Administrator,
the FAA amends 14 CFR part 39 as follows:

PART 39--AIRWORTHINESS DIRECTIVES

0
1. The authority citation for part 39 continues to read as follows:

    Authority: 49 U.S.C. 106(g), 40113, 44701.

Sec.  39.13  [Amended]

0
2. The Federal Aviation Administration (FAA) amends Sec.  39.13 by
adding the following new airworthiness directive (AD):

2007-16-19 Boeing: Amendment 39-15158. Docket No. FAA-2007-28940;
Directorate Identifier 2007-NM-131-AD.

Effective Date

    (a) This AD becomes effective August 28, 2007.

Affected ADs

    (b) None.

Applicability

    (c) This AD applies to Boeing Model 747-200B, 747-300, and 747-
400 series airplanes, certificated in any category; as identified in
Boeing Alert Service Bulletin 747-53A2610, dated May 10, 2007.

Unsafe Condition

    (d) This AD results from cracks found in the aft tension tie
channels at four station locations, on a Model 747-200B series
airplane that had been modified to a special freighter. We are
issuing this AD to detect and correct cracking of the aft tension
tie channels; failure of more than one tension tie could result in
rapid depressurization of the airplane.

Compliance

    (e) You are responsible for having the actions required by this
AD performed within the compliance times specified, unless the
actions have already been done.

Repetitive Inspections

    (f) At the applicable times specified in paragraph 1.E. of
Boeing Alert Service Bulletin 747-53A2610, dated May 10, 2007,
except as provided by paragraph (g) of this AD: Do repetitive
detailed inspections for cracking of the aft tension tie channels
from body station (BS) 1120 to BS 1220 and from BS 880 to BS 1100,
and do all applicable corrective actions, by accomplishing all of
the applicable actions specified in the Accomplishment Instructions
of Boeing Alert Service Bulletin 747-53A2610, dated May 10, 2007,
except as provided by paragraph (h) of this AD.

Exception to Compliance Times

    (g) Where Boeing Alert Service Bulletin 747-53A2610, dated May
10, 2007, specifies counting the compliance time from ``* * * after
the date on this service bulletin,'' this AD requires counting the
compliance time from the effective date of this AD.

Exception for Bolt Hole Cracks

    (h) If any crack is found in a bolt hole during any inspection
required by this AD, and Boeing Alert Service Bulletin 747-53A2610,
dated May 10, 2007, specifies to contact Boeing for appropriate
action: Before further flight, repair the crack using a method
approved in accordance with the procedures specified in paragraph
(j) of this AD.

Optional Terminating Action

    (i) Except as provided by paragraph (h) of this AD,
accomplishing the applicable repairs or modifications at all tension
tie locations, in accordance with Part 3 of the Accomplishment
Instructions of Boeing Alert Service Bulletin 747-53A2610, dated May
10, 2007, terminates the repetitive inspections required by
paragraph (f) of this AD.

Alternative Methods of Compliance (AMOCs)

    (j)(1) The Manager, Seattle Aircraft Certification Office (ACO),
FAA, has the authority to approve AMOCs for this AD, if requested in
accordance with the procedures found in 14 CFR 39.19.
    (2) To request a different method of compliance or a different
compliance time for this AD, follow the procedures in 14 CFR 39.19.
Before using any approved AMOC on any airplane to which the AMOC
applies, notify your appropriate principal inspector (PI) in the FAA
Flight Standards District Office (FSDO), or lacking a PI, your local
FSDO.
    (3) An AMOC that provides an acceptable level of safety may be
used for any repair required by this AD, if it is approved by an
Authorized Representative for the Boeing Commercial Airplanes
Delegation Option Authorization Organization who has been authorized
by the Manager, Seattle ACO, to make those findings. For a repair
method to be approved, the repair must meet the certification basis
of the airplane, and the approval must specifically refer to this
AD.

Material Incorporated by Reference

    (k) You must use Boeing Alert Service Bulletin 747-53A2610,
dated May 10, 2007, to perform the actions that are required by this
AD, unless the AD specifies otherwise. The Director of the Federal
Register approved the incorporation by reference of this document in
accordance with 5 U.S.C. 552(a) and 1 CFR part 51. Contact Boeing
Commercial Airplanes, P.O. Box 3707, Seattle, Washington 98124-2207,
for a copy of this service information. You may review copies at the
FAA, Transport Airplane Directorate, 1601 Lind Avenue, SW., Renton,
Washington; or at the National Archives and Records Administration
(NARA). For information on the availability of this material at
NARA, call<PHONE_NUMBER>, or go to: http://www.archives.gov/federal-register/cfr/ibr-locations.html
.

    Issued in Renton, Washington, on August 2, 2007.
Ali Bahrami,
Manager, Transport Airplane Directorate, Aircraft Certification
Service.
[FR Doc. E7-15582 Filed 8-10-07; 8:45 am]

BILLING CODE 4910-13-P


[Federal Register Volume 78, Number 158 (Thursday, August 15, 2013)]
[Notices]
[Page 49749]
[FR Doc No: 2013-19823]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. OR13-29-000]

Williams Olefins Feedstock Pipelines, L.L.C.; Notice of Petition
for Declaratory Order

    Take notice that on August 6, 2013, pursuant to Rule 207(a)(2) of
the Commission's Rules of Practices and Procedure, 18 CFR
385.207(a)(2)(2012), Williams Olefins Feedstock Pipelines, L.L.C.,
filed a petition requesting a declaratory order finding that a proposed
Bayou Ethane Pipeline project is not subject to Commission's
jurisdiction because the transported ethane will only be used as
feedstock to produce ethylene, and not burned as fuel, as more fully
described in their petition.
    Any person desiring to intervene or to protest in this proceedings
must file in accordance with Rules 211 and 214 of the Commission's
Rules of Practice and Procedure (18 CFR 385.211 and 385.214) on or
before 5:00 p.m. Eastern time on the specified comment date. Protests
will be considered by the Commission in determining the appropriate
action to be taken, but will not serve to make protestants parties to
the proceeding. Anyone filing a motion to intervene or protest must
serve a copy of that document on the Petitioner.
    The Commission encourages electronic submission of protests and
interventions in lieu of paper, using the FERC Online links at http://www.ferc.gov. To facilitate electronic service, persons with Internet
access who will eFile a document and/or be listed as a contact for an
intervenor must create and validate an eRegistration account using the
eRegistration link. Select the eFiling link to log on and submit the
intervention or protests.
    Persons unable to file electronically should submit an original and
14 copies of the intervention or protest to the Federal Energy
Regulatory Commission, 888 First St. NE., Washington, DC 20426.
    The filings in the above proceedings are accessible in the
Commission's eLibrary system by clicking on the appropriate link in the
above list. They are also available for review in the Commission's
Public Reference Room in Washington, DC. There is an eSubscription link
on the Web site that enables subscribers to receive email notification
when a document is added to a subscribed docket(s). For assistance with
any FERC Online service, please email<EMAIL_ADDRESS>or
call<PHONE_NUMBER> (toll free). For TTY, call<PHONE_NUMBER>.
    Comment Date: 5:00 p.m. Eastern time on Friday, September 6, 2013.

    Dated: August 8, 2013.
Kimberly D. Bose,
Secretary.
[FR Doc. 2013-19823 Filed 8-14-13; 8:45 am]
BILLING CODE 6717-01-P


[Federal Register Volume 77, Number 182 (Wednesday, September 19, 2012)]
[Notices]
[Page 58124]
[FR Doc No: 2012-23026]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Project No. 6492-009]

Hardins Manufacturing Company, Hardins Resources Company; Notice
of Transfer of Exemption

    1. By email filed April 23, 2012, Hardins Manufacturing Company
informed the Commission that its exemption from licensing for the
Hardins Hydro-Power Project No. 6492, originally issued December 8,
1982,\1\ has been transferred to Hardins Resources Company. The project
is located on the South Fork, Catawba River in Gaston County, North
Carolina. The transfer of an exemption does not require Commission
approval.
---------------------------------------------------------------------------

    \1\ 21 FERC ] 62,400, Order Granting Exemption From Licensing of
a Small Hydroelectric Project of 5 Megawatts or Less.
---------------------------------------------------------------------------

    2. Hardins Resources Company, located at 11800 Henderson Road,
Clifton, VA 20124 is now the exemptee of the Hardins Hydro-Power
Project No. 6492.

    Dated: September 12, 2012.
Kimberly D. Bose,
Secretary.
[FR Doc. 2012-23026 Filed 9-18-12; 8:45 am]
BILLING CODE 6717-01-P


[Federal Register Volume 86, Number 87 (Friday, May 7, 2021)]
[Notices]
[Pages 24641-24643]
[FR Doc No: 2021-09631]

-----------------------------------------------------------------------

DEPARTMENT OF HOMELAND SECURITY

Federal Emergency Management Agency

[Docket ID FEMA-2021-0002; Internal Agency Docket No. FEMA-B-2129]

Proposed Flood Hazard Determinations

AGENCY: Federal Emergency Management Agency, Department of Homeland
Security.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Comments are requested on proposed flood hazard
determinations, which may include additions or modifications of any
Base Flood Elevation (BFE), base flood depth, Special Flood Hazard Area
(SFHA) boundary or zone designation, or regulatory floodway on the
Flood Insurance Rate Maps (FIRMs), and where applicable, in the
supporting Flood Insurance Study (FIS) reports for the communities
listed in the table below. The purpose of this notice is to seek
general information and comment regarding the preliminary FIRM, and
where applicable, the FIS report that the Federal Emergency Management
Agency (FEMA) has provided to the affected communities. The FIRM and
FIS report are the basis of the floodplain management measures that the
community is required either to adopt or to show evidence of having in
effect in order to qualify or remain qualified for participation in the
National Flood Insurance Program (NFIP). In addition, the FIRM and FIS
report, once effective, will be used by insurance agents and others to
calculate appropriate flood insurance premium rates for new buildings
and the contents of those buildings.

DATES: Comments are to be submitted on or before August 5, 2021.

ADDRESSES: The Preliminary FIRM, and where applicable, the FIS report
for each community are available for inspection at both the online
location https://hazards.fema.gov/femaportal/prelimdownload and the
respective Community Map Repository address listed in the tables below.
Additionally, the current effective FIRM and FIS report for each
community are accessible online through the FEMA Map Service Center at
https://msc.fema.gov for comparison.
    You may submit comments, identified by Docket No. FEMA-B-2129, to
Rick Sacbibit, Chief, Engineering Services Branch, Federal Insurance
and Mitigation Administration, FEMA, 400 C Street SW, Washington, DC
20472,<PHONE_NUMBER>, or (email<EMAIL_ADDRESS>
FOR FURTHER INFORMATION CONTACT: Rick Sacbibit, Chief, Engineering
Services Branch, Federal Insurance and Mitigation Administration, FEMA,
400 C Street SW, Washington, DC 20472,<PHONE_NUMBER>, or (email)
<EMAIL_ADDRESS>or visit the FEMA Mapping and Insurance
eXchange (FMIX) online at https://www.floodmaps.fema.gov/fhm/fmx_main.html.

SUPPLEMENTARY INFORMATION: FEMA proposes to make flood hazard
determinations for each community listed below, in accordance with
section 110 of the Flood Disaster Protection Act of 1973, 42 U.S.C.
4104, and 44 CFR 67.4(a).
    These proposed flood hazard determinations, together with the
floodplain management criteria required by 44 CFR 60.3, are the minimum
that are required. They should not be construed to mean that the
community must change any existing ordinances that are more stringent
in their floodplain management requirements. The community may at any
time enact stricter requirements of its own or pursuant to policies
established by other Federal, State, or regional entities. These flood
hazard determinations are used to meet the floodplain management
requirements of the NFIP and are used to calculate the appropriate
flood insurance premium rates for new buildings built after the FIRM
and FIS report become effective.
    The communities affected by the flood hazard determinations are
provided in the tables below. Any request for reconsideration of the
revised flood hazard information shown on the Preliminary FIRM and FIS
report that satisfies the data requirements outlined in 44 CFR 67.6(b)
is considered an appeal. Comments unrelated to the flood hazard
determinations also will be considered before the FIRM and FIS report
become effective.
    Use of a Scientific Resolution Panel (SRP) is available to
communities in support of the appeal resolution process. SRPs are
independent panels of experts in hydrology, hydraulics, and other
pertinent sciences established to review conflicting scientific and
technical data and provide recommendations for resolution. Use of the
SRP only may be exercised after FEMA and local communities have been
engaged in a collaborative consultation process for at least 60 days
without a mutually acceptable resolution of an appeal. Additional
information regarding the SRP process can be found online at https://www.floodsrp.org/pdfs/srp_overview.pdf.
    The watersheds and/or communities affected are listed in the tables
below. The Preliminary FIRM, and where applicable, FIS report for each
community are available for inspection at both the online location
https://hazards.fema.gov/femaportal/prelimdownload and the respective
Community Map Repository address listed in the tables. For communities
with multiple ongoing Preliminary studies, the studies can be
identified by the unique project number and Preliminary FIRM date
listed in the tables. Additionally, the current effective FIRM and FIS
report for each community are accessible online through the FEMA Map
Service Center at https://msc.fema.gov for comparison.

(Catalog of Federal Domestic Assistance No. 97.022, ``Flood
Insurance.'')

Michael M. Grimm,
Assistant Administrator for Risk Management, Department of Homeland
Security, Federal Emergency Management Agency.

------------------------------------------------------------------------
                                             Community map repository
               Community                             address
------------------------------------------------------------------------
             Larimer County, Colorado and Incorporated Areas
         Project: 19-08-0002S Preliminary Date: January 26, 2021
------------------------------------------------------------------------
City of Fort Collins...................  Stormwater Utilities
                                          Department, 700 Wood Street,
                                          Fort Collins, CO 80521.
City of Loveland.......................  Public Works Department, 2525
                                          West 1st Street, Loveland, CO
                                          80537.
Town of Estes Park.....................  Town Hall, 170 MacGregor
                                          Avenue, Estes Park, CO 80517.
Town of Johnstown......................  Town Hall, 450 South Parish
                                          Avenue, Johnstown, CO 80534.
Town of Timnath........................  Town of Timnath Map Repository,
                                          TST Inc., 748 Whalers Way,
                                          Fort Collins, CO 80525.
Town of Wellington.....................  Town Hall, 3735 Cleveland
                                          Avenue, Wellington, CO 80549.
Unincorporated Areas of Larimer County.  Larimer County Courthouse,
                                          Offices Building, 200 West Oak
                                          Street, Suite 3000, Fort
                                          Collins, CO 80521.
------------------------------------------------------------------------
            Montour County, Pennsylvania (All Jurisdictions)
         Project: 15-03-0227S Preliminary Date: October 30, 2020
------------------------------------------------------------------------
Borough of Danville....................  Municipal Building, 463 Mill
                                          Street, Danville, PA 17821.
Township of Mahoning...................  Township of Mahoning Municipal
                                          Building, 849 Bloom Road,
                                          Danville, PA 17821.
------------------------------------------------------------------------
               Dallas County, Texas and Incorporated Areas
        Project: 20-06-0070S Preliminary Date: November 13, 2020
------------------------------------------------------------------------
City of Carrollton.....................  Engineering Department, 1945
                                          East Jackson Road, Carrollton,
                                          TX 75006.
City of Cedar Hill.....................  Public Works Department, 285
                                          Uptown Boulevard, Cedar Hill,
                                          TX 75104.
City of Combine........................  City Hall, 123 Davis Road,
                                          Combine, TX 75159.
City of Coppell........................  City Engineering Department,
                                          265 East Parkway Boulevard,
                                          Coppell, TX 75019.
City of Dallas.........................  Dallas Water Utilities,
                                          Stormwater Operations, 320
                                          East Jefferson Boulevard, Room
                                          312, Dallas, TX 75203.
City of Duncanville....................  Public Works Department, 203
                                          East Wheatland Road,
                                          Duncanville, TX 75116.
City of Farmers Branch.................  Public Works Department, 13000
                                          William Dodson Parkway,
                                          Farmers Branch, TX 75234.
City of Grand Prairie..................  Municipal Complex, Stormwater
                                          Department, 300 West Main
                                          Street, Grand Prairie, TX
                                          75050.
City of Hutchins.......................  City Hall, 321 North Main
                                          Street, Hutchins, TX 75141.
City of Irving.........................  Capital Improvement Program
                                          Department, 825 West Irving
                                          Boulevard, Irving, TX 75060.
City of Lancaster......................  Development Services, 700 East
                                          Main Street, Lancaster, TX
                                          75146.
City of Mesquite.......................  Engineering Division, 1515
                                          North Galloway Avenue,
                                          Mesquite, TX 75149.
City of Seagoville.....................  City Hall, 702 North Highway
                                          175, Seagoville, TX 75159.
City of University Park................  University Park Community
                                          Development Department, 4420
                                          Worcola Street, Dallas, TX
                                          75206.
City of Wilmer.........................  Public Works Department, 128
                                          North Dallas Avenue, Wilmer,
                                          TX 75172.
Town of Addison........................  Service Center, Public Works
                                          and Engineering, 16801
                                          Westgrove Drive, Addison, TX
                                          75001.
Town of Sunnyvale......................  Development Services
                                          Department, 127 North Collins
                                          Road, Sunnyvale, TX 75182.
Unincorporated Areas of Dallas County..  Dallas County Public Works
                                          Department, 411 Elm Street,
                                          4th Floor, Dallas, TX 75202.
------------------------------------------------------------------------
              Tarrant County, Texas and Incorporated Areas
        Project: 20-06-0071S Preliminary Date: November 13, 2020
------------------------------------------------------------------------
City of Arlington......................  City Hall, 101 West Abram
                                          Street, Arlington, TX 76010.
City of Bedford........................  Engineering Department, 1805 L.
                                          Don Dodson Drive, Bedford, TX
                                          76021.
City of Benbrook.......................  City Hall, 911 Winscott Road,
                                          Benbrook, TX 76126.
City of Colleyville....................  Public Works--Engineering
                                          Division, 100 Main Street, 2nd
                                          Floor, Colleyville, TX 76034.
City of Dalworthington Gardens.........  City Hall, 2600 Roosevelt
                                          Drive, Dalworthington Gardens,
                                          TX 76016.
City of Euless.........................  City Hall, 201 North Ector
                                          Drive, Euless, TX 76039.
City of Forest Hill....................  City Hall, 3219 California
                                          Parkway, Forest Hill, TX
                                          76119.
City of Fort Worth.....................  Department of Transportation
                                          and Public Works, 200 Texas
                                          Street, 2nd Floor, Fort Worth,
                                          TX 76102.
City of Grand Prairie..................  Municipal Complex, Stormwater
                                          Department, 300 West Main
                                          Street, Grand Prairie, TX
                                          75050.
City of Grapevine......................  City Hall, 200 South Main
                                          Street, Grapevine, TX 76051.

City of Haltom City....................  Municipal Services Center, 4200
                                          Hollis Street, Haltom City, TX
                                          76117.
City of Haslet.........................  City Hall, 101 Main Street,
                                          Haslet, TX 76052.
City of Hurst..........................  City Hall, Engineering
                                          Division, 1505 Precinct Line
                                          Road, Hurst, TX 76054.
City of Keller.........................  City Hall, 1100 Bear Creek
                                          Parkway, Keller, TX 76248.
City of Kennedale......................  City Hall, 405 Municipal Drive,
                                          Kennedale, TX 76060.
City of Mansfield......................  City Hall, 1200 East Broad
                                          Street, Mansfield, TX 76063.
City of North Richland Hills...........  City Hall 4301 City Point
                                          Drive, 1st Floor, North
                                          Richland Hills, TX 76180.
City of Richland Hills.................  City Hall, 3200 Diana Drive,
                                          Richland Hills, TX 76118.
City of River Oaks.....................  City Hall, 4900 River Oaks
                                          Boulevard, River Oaks, TX
                                          76114.
City of Saginaw........................  City Hall, 333 West McLeroy
                                          Boulevard, Saginaw, TX 76179.
City of Southlake......................  Public Works Department,
                                          Administrative and
                                          Engineering, 1400 Main Street,
                                          Suite 320, Southlake, TX
                                          76092.
City of Watauga........................  Service Center, Public Works,
                                          7800 Virgil Anthony Boulevard,
                                          1st Floor, Watauga, TX 76148.
City of Westworth Village..............  City Hall, 311 Burton Hill
                                          Road, Westworth Village, TX
                                          76114.
City of White Settlement...............  Administration Building, 214
                                          Meadow Park Drive, White
                                          Settlement, TX 76108.
Town of Pantego........................  Town Hall, 1614 South Bowen
                                          Road, Pantego, TX 76013.
Unincorporated Areas of Tarrant County.  Tarrant County Transportation
                                          Department--Engineering, 100
                                          East Weatherford Street, Suite
                                          401, Fort Worth, TX 76196.
------------------------------------------------------------------------
               City of Fairfax, Virginia, Independent City
        Project: 14-03-3327S Preliminary Date: September 25, 2020
------------------------------------------------------------------------
City of Fairfax........................  Department of Public Works,
                                          10455 Armstrong Street, City
                                          Hall Annex, Room 200 A,
                                          Fairfax, VA 22030.
------------------------------------------------------------------------

[FR Doc. 2021-09631 Filed 5-6-21; 8:45 am]
BILLING CODE 9110-12-P


[Federal Register: September 29, 2009 (Volume 74, Number 187)]
[Notices]
[Page 49880-49881]
[DOCID:fr29se09-62]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2009-N-0664]

Blood Products Advisory Committee; Notice of Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

    This notice announces a forthcoming meeting of a public advisory
committee of the Food and Drug Administration (FDA). At least one
portion of the meeting will be closed to the public.

    Name of Committee: Blood Products Advisory Committee.
    General Function of the Committee: To provide advice and
recommendations to the agency on FDA's regulatory issues.
    Date and Time: The meeting will be held on November 16, 2009,
from 8 a.m. to 5:30 p.m. and on November 17, 2009, from 8 a.m. to 5
p.m.
    Location: Bethesda Marriott Hotel, 5151 Pooks Hill Rd.,
Bethesda, MD 20814.
    Contact Person: William Freas or Pearline K. Muckelvene, Center
for Biologics Evaluation and Research (CBER), Food and Drug
Administration, 1401 Rockville Pike (HFM-71), Rockville, MD 20852,
301-827-0314, or FDA Advisory Committee Information Line, 1-800-741-
8138<PHONE_NUMBER> in the Washington, DC area), code<PHONE_NUMBER>.
Please call the Information Line for up-to-date information on this
meeting. A notice in the Federal Register about last minute
modifications that impact a previously announced advisory committee
meeting cannot always be published quickly enough to provide timely
notice. Therefore, you should always check the agency's Web site and
call the appropriate advisory committee hot line/phone line to learn
about possible modifications before coming to the meeting.
    Agenda: On November 16, 2009, in the morning the Committee will
hear updates on the following topics: the HHS Advisory Committee on
Blood Safety and Availability, Dengue virus outbreak, and 2009 A/
H1N1 Pandemic and the impact on blood safety and availability. The
Committee will then discuss blood donor deferral for malaria risk
associated with travel to Mexico. In the afternoon the Committee
will discuss the design of a new phase III study of pathogen
inactivation of human platelets using the Cerus, INTERCEPT Blood
System. On November 17, 2009, in the morning the Committee will
discuss blood pressure and pulse as blood donor eligibility
criteria, and in the afternoon the committee will discuss the public
health need and performance characteristics of over-the-counter
home-use HIV test kits.
    FDA intends to make background material available to the public
no later than 2 business days before the meeting. If FDA is unable
to post the background material on its Web site prior to the
meeting, the background

material will be made publicly available at the location of the
advisory committee meeting, and the background material will be
posted on FDA's Web site after the meeting. Background material is
available at http://www.fda.gov/AdvisoryCommittees/Calendar/
default.htm. Scroll down to the appropriate advisory committee link.
    Procedure: On November 16, 2009, from 8 a.m. to 5:30 p.m. and on
November 17, 2009, from 8 a.m. to 3:15 p.m., the meeting is open to
the public. Interested persons may present data, information, or
views, orally or in writing, on issues pending before the committee.
Written submissions may be made to the contact person on or before
November 9, 2009. Oral presentations from the public will be
scheduled between approximately 11 a.m. and 11:30 a.m. and between 4
p.m. and 4:30 p.m. on November 16, 2009, and between approximately
10:30 a.m. and 11 a.m., and 2:15 and 2:45 p.m. on November 17, 2009.
Those desiring to make formal oral presentations should notify the
contact person and submit a brief statement of the general nature of
the evidence or arguments they wish to present, the names and
addresses of proposed participants, and an indication of the
approximate time requested to make their presentation on or before
October 30, 2009. Time allotted for each presentation may be
limited. If the number of registrants requesting to speak is greater
than can be reasonably accommodated during the scheduled open public
hearing session, FDA may conduct a lottery to determine the speakers
for the scheduled open public hearing session. The contact person
will notify interested persons regarding their request to speak by
November 2, 2009.
    Closed Committee Deliberations : On November 17, 2009, from
approximately 3 p.m. until 5 p.m., the meeting will be closed to
permit discussion and review of trade secret and/or confidential
commercial information (5 U.S.C. 552b(c)(4)). The committee will
hear presentations and discuss sponsor, trade secret and
confidential information.
    Persons attending FDA's advisory committee meetings are advised
that the agency is not responsible for providing access to
electrical outlets.
    FDA welcomes the attendance of the public at its advisory
committee meetings and will make every effort to accommodate persons
with physical disabilities or special needs. If you require special
accommodations due to a disability, please contact William Freas or
Pearline K. Muckelvene at least 7 days in advance of the meeting.
    FDA is committed to the orderly conduct of its advisory
committee meetings. Please visit our Web site at http://www.fda.gov/
AdvisoryCommittees/AboutAdvisoryCommittees/ucm111462.htm for
procedures on public conduct during advisory committee meetings.
    Notice of this meeting is given under the Federal Advisory
Committee Act (5 U.S.C. app. 2).

    Dated: September 23, 2009.
David Horowitz,
Assistant Commissioner for Policy.
[FR Doc. E9-23434 Filed 9-28-09; 8:45 am]

BILLING CODE 4160-01-S


[Federal Register: July 17, 2006 (Volume 71, Number 136)]
[Notices]
[Page 40493-40494]
[DOCID:fr17jy06-49]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

Notice of Application Accepted for Filing and Soliciting Motions
To Intervene, Protests, and Comments

July 10, 2006.
    Take notice that the following hydroelectric application has been
filed with the Commission and is available for public inspection:
    a. Type of Application: Preliminary Permit.
    b. Project No.: 12671-000.
    c. Date filed: April 10, 2006.
    d. Applicant: Greenmill Hydro, LLC.
    e. Name of Project: Greenmill Project.
    f. Location: The project would be located on a water supply
pipeline taken from Whatcom Creek, in Whatcom County, Washington. The
project would not occupy Federal or Tribal lands. No dam would be used
for this project.
    g. Filed Pursuant to: Federal Power Act, 16 U.S.C. 791(a)-825(r).
    h. Applicant Contact: Mr. Richard New, Greenmill Hydro, LLC, 5500
Blue Heron Lane, Deming, WA 98244,<PHONE_NUMBER>.
    i. FERC Contact: Robert Bell,<PHONE_NUMBER>.
    j. Deadline for filing comments, protests, and motions to
intervene: 60 days from the issuance date of this notice.
    The Commission's Rules of Practice and Procedure require all
intervenors filing documents with the Commission to serve a copy of
that document on each person in the official service list for the
project. Further, if an intervenor files comments or documents with the
Commission relating to the merits of an issue that may affect the
responsibilities of a particular resource agency, they must also serve
a copy of the document on that resource agency.
    k. Description of Project: The proposed project would consist of:
(1) A proposed powerhouse containing three new generating units having
a total installed capacity of 1200-kilowatts, (2) a proposed 0.25-mile-
long, 6.9-kilovolt transmission line, and (3) appurtenant facilities.
The project would have an annual generation of 5 gigawatt hours that
would be sold to a local utility.
    l. Locations of Applications: A copy of the application is
available for inspection and reproduction at the Commission in the
Public Reference Room, located at 888 First Street NE., Room 2A,
Washington DC 20426, or by calling<PHONE_NUMBER>. This filing may also
be viewed on the Commission's Web site at http://www.ferc.gov using the

``eLibrary'' link. Enter the docket number excluding the last three
digits in the docket number field to access the document. For
assistance, call toll-free 1-866-208-3676 or e-mail
<EMAIL_ADDRESS>For TTY, call<PHONE_NUMBER>. A copy is

also available for inspection and reproduction at the address in item h
above.
    m. Individuals desiring to be included on the Commission's mailing
list should so indicate by writing to the Secretary of the Commission.
    n. Competing Preliminary Permit--Anyone desiring to file a
competing application for preliminary permit for a proposed project
must submit the competing application itself, or a notice of intent to
file such an application, to the Commission on or before the specified
comment date for the particular application (see 18 CFR 4.36).
Submission of a timely notice of intent allows an interested person to
file the competing preliminary permit application no later than 30 days
after the specified comment date for the particular application. A
competing preliminary permit application must conform with 18 CFR
4.30(b) and 4.36.
    o. Competing Development Application--Any qualified development
applicant desiring to file a competing development application must
submit to the Commission, on or before a specified comment date for the
particular application, either a competing development application or a
notice of intent to file such an application. Submission of a timely
notice of intent to file a development application allows an interested
person to file the competing application no later than 120 days after
the specified comment date for the particular application. A competing
license application must conform with 18 CFR 4.30(b) and 4.36.
    p. Notice of Intent--A notice of intent must specify the exact
name, business address, and telephone number of the prospective
applicant, and must include an unequivocal statement of intent to
submit, if such an application may be filed, either a preliminary
permit application or a development application (specify which type of
application). A notice of intent must be served on the applicant(s)
named in this public notice.
    q. Proposed Scope of Studies under Permit--A preliminary permit, if
issued, does not authorize construction. The term of the proposed
preliminary permit would be 36 months. The work proposed under the
preliminary permit would include economic analysis, preparation of
preliminary engineering plans, and a study of environmental impacts.
Based on the results of these studies, the Applicant would decide
whether to proceed with the preparation of a development application to
construct and operate the project.
    r. Comments, Protests, or Motions to Intervene--Anyone may submit
comments, a protest, or a motion to intervene in accordance with the
requirements of Rules of Practice and Procedure, 18 CFR 385.210, .211,
.214. In determining the appropriate action to take, the Commission
will consider all protests or other comments filed, but only those who
file a motion to

intervene in accordance with the Commission's Rules may become a party
to the proceeding. Any comments, protests, or motions to intervene must
be received on or before the specified comment date for the particular
application.
    Comments, protests and interventions may be filed electronically
via the Internet in lieu of paper. See 18 CFR 385.2001(a)(1)(iii) and
the instructions on the Commission's Web site under ``e-filing'' link.
The Commission strongly encourages electronic filing.
    s. Filing and Service of Responsive Documents--Any filings must
bear in all capital letters the title ``COMMENTS'', ``COMPETING
APPLICATION'', ``RECOMMENDATIONS FOR TERMS AND CONDITIONS'',
``PROTEST'', OR ``MOTION TO INTERVENE'', as applicable, and the Project
Number of the particular application to which the filing refers. Any of
the above-named documents must be filed by providing the original and
the number of copies provided by the Commission's regulations to: The
Secretary, Federal Energy Regulatory Commission, 888 First Street, NE.,
Washington, DC 20426. A copy of any motion to intervene must also be
served upon each representative of the Applicant specified in the
particular application.
     t. Agency Comments--Federal, state, and local agencies are invited
to file comments on the described application. A copy of the
application may be obtained by agencies directly from the Applicant. If
an agency does not file comments within the time specified for filing
comments, it will be presumed to have no comments. One copy of an
agency's comments must also be sent to the Applicant's representatives.

Magalie R. Salas,
Secretary.
[FR Doc. E6-11192 Filed 7-14-06; 8:45 am]

BILLING CODE 6717-01-P


[Federal Register: April 19, 2006 (Volume 71, Number 75)]
[Notices]
[Page 20143-20144]
[DOCID:fr19ap06-143]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[Securities Act of 1933 Release No. 8677]
[Securities Exchange Act of 1934 Release No. 53642]

Order Regarding Review of Financial Accounting Standards Board
Accounting Support Fee for 2006 Under Section 109 of The Sarbanes-Oxley
Act of 2002

April 13, 2006.
    The Sarbanes-Oxley Act of 2002 (the ``Act'') establishes criteria
that must be met in order for the accounting standards established by
an accounting standard-setting body to be recognized as ``generally
accepted'' for purposes of the federal securities laws. Section 109 of
the Act provides that all of the budget of an accounting standard-
setting body satisfying these criteria shall be payable from an annual
accounting support fee assessed and collected against each issuer, as
may be necessary or appropriate to pay for the budget and provide for
the expenses of the standard setting body, and to provide for an
independent, stable source of funding, subject to review by the
Securities and Exchange Commission (the ``Commission''). Under Section
109(f), the annual accounting support fee shall not exceed the amount
of the standard setter's ``recoverable budget expenses.'' Section
109(h) amends Section 13(b)(2) of the Securities Exchange Act of 1934
to require issuers to pay the allocable share of a reasonable annual
accounting support fee or fees, determined in accordance with Section
109 of the Act.
    On April 25, 2003, the Commission issued a policy statement
concluding that the Financial Accounting Standards Board (``FASB'') and
its parent organization, the Financial Accounting Foundation (``FAF''),
satisfied the criteria for an accounting standard-setting body under
the Act, and recognizing the FASB's financial accounting and reporting
standards as ``generally accepted'' under Section 108 of the Act.\1\ As
a consequence of that recognition, the Commission undertook a review of
the FASB's accounting support fee for calendar year 2006. In connection
with its review, the Commission also reviewed the proposed

budget for the FAF and the FASB for calendar year 2006.
---------------------------------------------------------------------------

    \1\ Financial Reporting Release No. 70.
---------------------------------------------------------------------------

    Section 109 of the Act also provides that the standard setting body
can have additional sources of revenue for its activities, such as
earnings from sales of publications, provided that each additional
source of revenue shall not jeopardize the actual or perceived
independence of the standard setter. In this regard, the Commission
also considered the interrelation of the operating budgets of the FAF,
the FASB and the Government Accounting Standards Board (``GASB''), the
FASB's sister organization, which sets accounting standards used by
state and local government entities. The Commission has been advised by
the FAF that neither the FAF, the FASB nor the GASB accept
contributions from the accounting profession.
    After its review, the Commission determined that the 2006 annual
accounting support fee for the FASB is consistent with Section 109 of
the Act. Accordingly,
    It is ordered, pursuant to Section 109 of the Act, that the FASB
may act in accordance with this determination of the Commission.

    By the Commission.
Nancy M. Morris,
Secretary.
[FR Doc. E6-5798 Filed 4-18-06; 8:45 am]

BILLING CODE 8010-01-P